|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00383 TIANAN MEDICARE
Nominal 
0.750 -0.070 (-8.537%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 1,568,824 | 9.108% | 1,437,863 | 1,463,495 | 1,194,148 | 1,841,346 |
| Cost of Sales | (1,282,604) | 9.409% | (1,172,307) | (1,196,037) | (973,416) | (1,479,613) |
| Gross Profit | 286,220 | 7.781% | 265,556 | 267,458 | 220,732 | 361,733 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (34,043) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 35,404 | -- | (117,169) | (110,468) | (96,562) | (28,811) | |
| Taxation | (14,912) | 654.656% | (1,976) | (16,802) | (8,577) | 38,611 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (9,197) | 107.654% | (4,429) | (10,026) | (6,789) | (7,624) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 11,295 | -- | (123,574) | (137,296) | (111,928) | 2,176 | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 23,341 | -57.606% | 55,057 | 56,825 | 45,846 | 68,724 |
| Depreciation & Amortisation | 98,218 | -6.185% | 104,693 | 104,529 | 116,431 | 161,905 |
| Directors' Emoluments | 4,992 | 51.733% | 3,290 | 4,188 | 4,885 | 7,582 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 1.220 | -- | -16.940 | -18.752 | -15.290 | 0.297 |
| DPS (cts) | 1.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 81.967% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.385 | -- | 0.097 | 0.303 | (0.001) | 0.018 |
| NBV per share ($) | 1.724 | -- | 2.124 | 2.323 | 2.438465 | 2.465174 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 21,659,000 |
| %Change | 1553.359% |
| EPS / (LPS) | HKD 0.020 |
| NBV Per Share ($) | HKD 1.675 |